Dr. Brianna Olamiju is a distinguished dermatologist, with a clinical and research focus on complex medical dermatology, skin of color, alopecia, and oncodermatology. She attended Yale School of Medicine and completed dermatology training at Weill Cornell New York Presbyterian.

Dr. Olamiju is widely published, with over 25 peer-reviewed journal articles, multiple textbook chapters, and national presentations covering a broad range of dermatologic topics—from immune-related adverse events in cancer patients to novel treatments for vitiligo and alopecia. Her work has been featured in journals such as JAMA Dermatology, Journal of the American Academy of Dermatology, Pediatric Dermatology, and Cutis.

Professional Associations

• American Academy of Dermatology (AAD)
• Women’s Dermatologic Society (WDS)
• Skin of Color Society
• American Society for Dermatologic Surgery
• Association of Academic Cosmetic Dermatology
• Dermatologic Society of Greater New York
• National Medical Association

Selected Publications

• Olamiju B, Craiglow B. Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent females. J Am Acad Dermatol. 2021.
• Ahmad M, Saeed S, Olamiju B, et al. Dermatologic toxicities of chemotherapy: an educational intervention for skin of color women with breast cancer. Int J Womens Dermatol. 2023.
• Belzer A, Mortlock R, Olamiju B, et al. The spectrum of cutaneous immune-related adverse events in patients with skin of color. J Am Acad Dermatol. 2023.
• Olamiju B, Suozzi KC, Leffell DJ, et al. Clinical factors impacting clear margins of primary melanoma in situ with conventional excision. J Am Acad Dermatol. 2022.
• Olamiju B, Leventhal JS, Vesely MD. Crusted scabies presenting as erythroderma in a patient with iatrogenic immunosuppression. Cutis. 2023.

Dr. Amy Thorne is a double board-certified dermatologist and Mohs micrographic dermatologic surgeon. She has expertise in supportive oncodermatology, inherited cancer syndromes, hormonally driven dermatoses—such as those related to menopause, weight change, metabolic syndrome, and infertility—as well as psychocutaneous conditions, complex medical and cosmetic dermatology. Though Dr. Thorne completed a rigorous training program, she remains a student at heart and is most distinguished for a mutualistic commitment to her patients, who consistently remark on her generosity and kindness.

Dr. Thorne completed her dermatology residency at the University of Texas Health Science Center at San Antonio and holds additional training and credentials in occupational and environmental medicine, pedagogy, and literature. Her colleagues and patients have selected her for a number of leadership positions and awards of teaching excellence. With a strong background in diverse healing traditions, narrative medicine, and clinical innovation, Dr. Thorne has published extensively on cutaneous oncology, systemic disease manifestations, exposure-related skin conditions, and emerging dermatologic therapies.

Beyond her clinical and academic work, Dr. Thorne remains committed to physician advocacy and expanding access to specialized dermatologic care in underserved and resource-limited settings. She has been actively involved in humanitarian medicine, accumulating over 30,000 hours of service, providing expert guidance on field surgery and dermatologic conditions linked to toxic exposures during migration, poverty, and war.

Dr. Thorne is a content expert in a variety of subjects and venues including medico-legal case review, veterans’ compensation and pension determinations, peer-review of surgical cases, as well as technical writing, editing, and ghostwriting in the fields of medicine, agriculture, social sciences, literature, and film.

Professional Associations

• American Academy of Dermatology (AAD)
• American Society for Mohs Surgery (ASMS) 
• American Society for Dermatologic Surgery (ASDS)
• New Mexico Dermatology and Dermatologic Surgery Society

Post-Graduate Honors

• Former U.S. Department of State Fulbright Scholar 
• The Pegasus Physician Writers at Stanford University, Inducted as a Corresponding Member

Selected Publications

• Thorne A, Nguyen T. United States Patent & Trademark Office. Patent awarded for a topical dermatologic therapy. (2023)
• Shafique D, Hickman A, Elwood H, Thorne A, Zlotoff B. Pediatric Hematidrosis—A Case Report and Review of the Literature and Pathogenesis. Pediatric Dermatology (Aug. 2021)
• Won Oh C, Thorne A, Duke T, Lewis D, Talpur R, Duvic M. Waistband Mycosis Fungoides: A New Clinical Variant of Early-Stage Disease & Mimickers. Skinmed. Department of Dermatology, MD Anderson Cancer Center (Sept. 2019)
• Thorne A. HPV+ Oropharyngeal Squamous Cell Carcinoma in Mohs Surgeons, Dermatologists, and Other Physicians: An Occupational Hazard, Silent Epidemic, and Ethical Dilemma. Annual “Update on Skin Cancer” Meeting, American Society of Mohs Surgery (May 2019)
• Thorne A, Cohen J. Hansen’s Disease. In: Jackson-Richards D & Pandya A, eds. Dermatology Atlas for Skin of Color. First Edition. Springer (Oct. 2014).

Dr. George Romar is a highly accomplished dermatologist specializing in complex medical dermatology, contact dermatitis, alopecia, and medical innovation. Dr. Romar graduated magna cum laude from Harvard Medical School, where he was honored for his outstanding academic achievements and contributions to dermatological research. He has a particular focus on drug hypersensitivity reactions, graft-versus-host disease (GVHD), and cutaneous T-cell responses. He completed his dermatology residency at Albert Einstein College of Medicine-Montefiore, where he was recognized for his clinical excellence and leadership skills.

Professional Associations Dr. Romar is an active member of several professional associations, including:

• American Academy of Dermatology (AAD)
• Society for Investigative Dermatology (SID)
• American Society for Dermatologic Surgery (ASDS)

Innovation & Research Dr. Romar has unique expertise in research and innovation, significantly contributing to the fields of dermatology and dermatologic surgery. His work on drug hypersensitivity reactions, graft-versus-host disease, and cutaneous T-cell responses has been published in esteemed journals. He has presented his findings at numerous national and international conferences, reflecting his commitment to advancing dermatological care and knowledge. Dr. Romar's research continues to influence clinical practices and improve patient outcomes.

Selected Publications Peer-Reviewed Journal Publications

• *Romar GA, *Li DJ, *Velasquez GA, Schunkert EM, Foreman RK, Divito SJ. “Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.” JAMA Dermatol. 2023 Aug 1;159(8):830-836.
• *Romar GA, *Li DJ, Hsieh PC, Wells M, Foreman RK, Lian CG, Divito SJ. “Histologic features of GVHD-associated angiomatosis: Insights into pathophysiology and treatment.” J Am Acad Dermatol. 2020 Sep;83(3):914-917.
• Romar GA, Kupper TS, Divito SJ. “Research Techniques Made Simple: Techniques to Assess Cell Proliferation.” J Invest Dermatol. 2016 Jan; 136(1):e1-7.
• Romar G, and Matthews KRW. “Considerations on U.S. Government Involvement in STEM Education and Early Childhood Interventions.” J Sci Pol and Gov (2013) Jun; 3(1):1-7. Abstracts - International
• Romar GA, Hsieh PC, Compton LA, Chiluiza D, and Divito SJ. “Skin resident memory T cells survive chemotherapy and mediate drug hypersensitivity reactions in the setting of profound lymphopenia.” 2018 International Investigative Dermatology, Orlando, FL. (2018)
• Hsieh PC, Romar GA, Wells M, Foreman R, Lian CG, and Divito SJ. “Insights into GVHD-associated Angiomatosis.” 2018 International Investigative Dermatology, Orlando, FL. (2018)
• Romar GA, and Divito SJ. “Retrospective Analysis Of SJS/TEN Cases Reveals Need For Diagnostic Test To Determine Culprit Drug.” EAACI 8th Drug Hypersensitivity Meeting, Amsterdam, The Netherlands. (2018)
• Romar GA, Hsieh P, Compton LA, Divito SJ. “Skin resident memory T cells survive chemotherapy and Immediate drug hypersensitivity reactions in the setting of profound lymphopenia.” International Investigative Dermatology, Orlando, FL. (2018) Abstracts - National
• Divito SJ, Elco CP, Romar GA, Cutler C, Kupper, TS. “Host skin T cells survive chemotherapy and transplant conditioning regiments and are present during acute GVHD.” J Invest Dermatol (2016) 136(5), S40.
• Romar GA, Compton LA, Kupper TS, Divito SJ. “Development of neutrophilic dermatoses in profoundly neutropenic patients.” J Invest Dermatol (2016) 136(5), S31.
• Divito SJ, Romar GA, Compton LA, and Kupper TS. “Neutrophil and lymphocyte-mediated skin disease despite profound leukopenia.” J Invest Dermatol (2015) 135, S28–S48.

Dr. Rachel Kang is a highly skilled dermatologist with an impressive background in complex medical dermatology and oncodermatology. Patients consistently commend her compassionate care and individualized approach to providing her patients comprehensive treatment plans.

Dr. Kang completed her dermatology residency and postdoctoral residency fellowship at New York-Presbyterian Hospital, where she was celebrated for her clinical excellence and leadership. Dr. Kang began her medical education at Cornell University, earning her BA, and went on to receive her MD from Weill Cornell Medical College, where she was honored for Excellence in Research. She also completed her preliminary year in Internal Medicine at Pennsylvania Hospital, where she was recognized for her outstanding performance. Dr. Kang is an Assistant Professor of Clinical Dermatology at Weill Cornell Medical College.

Professional Associations Dr. Kang is an active member of several professional associations, including:

• Society for Pediatric Dermatology
• American Academy of Dermatology (AAD)
• American Society for Dermatologic Surgery
• Women’s Dermatologic Society
• American Medical Association
• New York Korean American Medical Association

Innovation & Research Dr. Kang has an extensive background in innovation and research, with a particularly focus on dermatology and oncology. She has contributed significantly to various research initiatives, including her work with the Atkins Foundation Summer Research Fellowship and the Sandra and Edward Meyer Cancer Center. Dr. Kang's research encompasses the role of phosphatidylinositol 5-phosphate 4-kinase beta in lipolysis and the development of CRISPR-based immunotherapy for hematologic malignancies. Her work has been published in esteemed journals, highlighting her contributions to understanding and treating complex skin conditions and skin cancers. Dr. Kang has presented her groundbreaking findings at numerous national and international conferences, reflecting her commitment to advancing both dermatological care and oncology.

Selected Publications

• Kang R, Lipner S. Consumer Preferences of Antifungal Products for Treatment and Prevention of Tinea Pedis. Journal of Dermatological Treatment. 2019 Jan; 21:1-17.
• Kang R, Lipner S. Evaluation of Onychomycosis Information on the Internet. Journal of Drugs in Dermatology. 2019 May; 18(5):484
• Kang R, Lipner S. Social Media and Dissemination: Impressions of Fish Pedicures Following a Case of Onychomadesis. Dermatology Online Journal. 2020 Mar; Pub Status: In-Press
• Hoellwarth J, Reif T, Mori S, Kang R, Magro C. Horrifying Basal Cell Carcinoma Presenting As Progressive Pyoderma Gangrenosum. Case Reports in Oncology. 2024, Feb; 17(1): 298-304
• Perez R, Kang R, Chen R, Castellanos J, Milewski A, Perez A. Computational Oncology. Journal of Oncopathology and Clinical Research. 2018, Mar; 2(1): 3.
• Perez RK, Chen R, Kang R, Perez AR. Advent of CRISPR Based Immunotherapy in Hematologic Malignancies. Journal of Oncopathology and Clinical Research. 2018, Mar; 2(1): 2.

Dr. Calvin Wu is a triple board-certified internist, pediatrician, and endocrinologist with a special interest in treating all forms of diabetes (including prediabetes and gestational diabetes). He is a passionate proponent of continuous glucose monitoring and other promising advances in diabetes technology/therapy, and has been championing a novel fully virtual multidisciplinary diabetes care model in his prior roles as the founding Lead Endocrinologist at Steady Health and Medical Director of Virtual Endocrinology at Carbon Health. He completed medical school at USC Keck School of Medicine, residency training at LAC+USC Medical Center, and an adult endocrinology fellowship at Harbor-UCLA Medical Center.

Professional Associations Innovation & Research Selected Publications

Dr. Divya Angra is a board-certified dermatologist specializing in medical, surgical, and cosmetic dermatology. A Maryland native, Dr. Angra received her medical degree (MD) from the George Washington University School of Medicine & Health Sciences. She completed her dermatology training at Howard University Hospital. She also holds a Bachelor of Arts in Economics from George Washington University as part of the seven-year BA and MD program. Dr. Angra enjoys practicing a combination of medical, surgical, and cosmetic dermatology. Dr. Angra is a fellow of the American Academy of Dermatology (AAD) and has published several peer-reviewed articles. She is passionate about educating her patients about their skin and providing holistic care.